908 Devices Inc. MASS 深 滬
等待開盤 10-03 09:30:00 美东时间
8.75
-0.240
-2.67%
華盛通- 最 高9.085
- 今 開9.05
- 成交量 31.73万股
- 最 低 8.64
- 昨 收 8.99
- 總市值 3.14亿
- 52周最高 9.085
- 市盈率 靜 --
- 換手率 0.88%
- 52周最低 1.81
- 委 比 81.14%
- 總股本 3586.12万
- 歷史最高 79.60
- 量 比 0.58
- 振 幅 4.95%
- 歷史最低 1.81
- 每 手 1
- 風險率 1.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Masivo Silver Corp. Advances Mining Projects Amid Filing Delays
An update from Masivo Silver Corp. ( ($TSE:MASS) ) is now available. Masivo Sil...
09-26 10:32
Masivo Silver Corp. Advances Exploration and Addresses Financial Filings
Masivo Silver Corp. ( ($TSE:MASS) ) just unveiled an announcement. Masivo Silve...
09-16 02:35
Masivo Silver Corp. Advances Exploration Amid Financial Filing Delays
The latest announcement is out from Masivo Silver Corp. ( ($TSE:MASS) ). Masivo...
08-15 02:08
Cathie Wood Pounces On Peter Thiel-Backed Bullish Stock After Wild IPO Surge: Ark Buys Stock Worth $172.22 Million
Ark Invest, led by Cathie Wood, made big trades in Bullish and Shopify. They bought over 2.5 million shares of Bullish and sold over $3 million of Shopify stock.
08-14 09:46
908 Devices Inc. Reports Strong Growth and Optimism
908 Devices Inc. (($MASS)) has held its Q2 earnings call. Read on for the main ...
08-06 09:27
美股大行评级 | 潜在涨幅345.51%！BTIG上调Syndax Pharmaceuticals目标价至56美元，维持"买入"评级
今日重点评级关注：BTIG：维持Syndax Pharmaceuticals"买入"评级，目标价从43美元升至56美元；花旗：维持Syndax Pharmaceuticals"买入"评级，目标价从46美元升至51美元
08-06 09:30
Leerink Partners Upgrades 908 Devices to Outperform, Announces $12 Price Target
Leerink Partners analyst Puneet Souda upgrades 908 Devices (NASDAQ:MASS) from Market Perform to Outperform and announces $12 price target.
08-06 05:09
908 Devices shares are trading lower after the company reported mixed Q2 financial results.
908 Devices shares are trading lower after the company reported mixed Q2 financ...
08-05 23:37
908 Devices Raises FY2025 Sales Guidance from $53.000M-$55.000M to $54.000M-$56.000M vs $54.337M Est
908 Devices (NASDAQ:MASS) raises FY2025 sales outlook from $53.000 million-$55.000 million to $54.000 million-$56.000 million vs $54.337 million estimate.
08-05 19:49
908 Devices Q2 EPS $(0.36) Misses $(0.21) Estimate, Sales $13.04M Beat $12.17M Estimate
908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.21) by 71.43 percent. This is a 2.7 percent increase over losses of $(0.37) per share from the
08-05 19:07
